![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
- Brown N., Lumley J., Tickle C. and Keene J. (1997) Congenital limb reduction defects. Clues from development biology, teratology and epidemiology. London, HMSO.
- Chard T. and Macintosh M.C.M. (1995) Biochemical screening for Down's syndrome. In: Progress in Obstetrics and Gynaecology, 11, 39-55.
- Cuckle H. (1996) Biochemical and ultrasound screening for Down's syndrome: rival or partners? Ultrasound in Obstetrics and Gynecology, 7, 236-238.
- Gekas J., Gondry J., Mazur S., Cesbron P. and Thepot F. (1999) Informed consent to serum screening for Down's syndrome: are women given adequate information? Prenatal Diagnosis, 19, 1-7.
- Grewal G.K., Moss H.J., Aitken D.A., Bjornsson S., Cameron A.D. and Pell J.P. (1997) Factors affecting women's knowledge of antenatal serum screening. Scottish Medical Journal, 42, 111-113.
- Heikkila A., Ryynanen M., Kirkinen P. and Saarikoski S. (1997) Results and views of women in population-wide pregnancy screening for trisomy 21 in east Finland. Fetal Diagnosis and Therapy, 12, 93-96.
- Kornman L.H., Wortelboer M.J., Beekhuis J.R., Morssink L.P. and Mantingh A. (1997) Women's opinions and the implications of first versus second trimester screening for fetal Down's syndrome. Prenatal Diagnosis, 17, 1011-1018.
- McKeown K., Tonks A., Wyldes M.P. (1999) Down's Syndrome 1995-97. West Midlands Perinatal Congenital Anomaly Register, 12. Birmingham.
- Michie S., Smith D. and Marteau T.M. (1999) Prenatal tests: How are women deciding? Prenatal Diagnosis, 19, 743-748.
- Wald N.J., Kennard A., Hackshaw A. and McGuire A. (1997) Antenatal screening for Down's syndrome. Journal of Medical Screening, 4, 181-246.
Journal of Obstetrics and Gynaecology
Volume 22, 2002 - Issue 4